Literature DB >> 25561681

The DISCUSS Project: Revised Points to Consider for the Derivation of Induced Pluripotent Stem Cell Lines From Previously Collected Research Specimens.

Geoffrey P Lomax1, Sara Chandros Hull2, Rosario Isasi3.   

Abstract

Human somatic cell reprogramming is a leading technology for accelerating disease modeling and drug discovery. The Deriving Induced Stem Cells Using Stored Specimens (DISCUSS) project is a consensus-building initiative designed to consider how human somatic cells obtained under general biomedical research protocols can be used in induced pluripotent stem cell (iPSC) derivation. We previously published a draft list of points to consider for the use of previously collected specimens in iPSC research and then initiated a structured feedback and comment process. Here, we present a summary of this feedback and revised list of points to consider. ©AlphaMed Press.

Entities:  

Mesh：

Year:  2015        PMID： 25561681      PMCID： PMC4303360          DOI： 10.5966/sctm.2014-0192

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN： 2157-6564            Impact factor:   6.940


  8 in total

1.  The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider.

Authors:  Geoffrey P Lomax; Sara Chandros Hull; Justin Lowenthal; Mahendra Rao; Rosario Isasi
Journal:  Stem Cells Transl Med       Date:  2013-08-29       Impact factor: 6.940

2.  Familiarity and prudence of the Japanese public with research into induced pluripotent stem cells, and their desire for its proper regulation.

Authors:  Ryuma Shineha; Masahiro Kawakami; Koji Kawakami; Motohiko Nagata; Takashi Tada; Kazuto Kato
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

3.  Identifying personal genomes by surname inference.

Authors:  Melissa Gymrek; Amy L McGuire; David Golan; Eran Halperin; Yaniv Erlich
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

4.  2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories.

Authors: 
Journal:  Biopreserv Biobank       Date:  2012-04       Impact factor: 2.300

Review 5.  Challenges of biobanking in South Africa to facilitate indigenous research in an environment burdened with human immunodeficiency virus, tuberculosis, and emerging noncommunicable diseases.

Authors:  Akin Abayomi; Alan Christoffels; Ravnit Grewal; Locunda A Karam; Catherine Rossouw; Ciara Staunton; Carmen Swanepoel; Beverley van Rooyen
Journal:  Biopreserv Biobank       Date:  2013-11-22       Impact factor: 2.300

6.  Patients' attitudes toward the donation of biological materials for the derivation of induced pluripotent stem cells.

Authors:  Ishan Dasgupta; Juli Bollinger; Debra J H Mathews; Neil M Neumann; Abbas Rattani; Jeremy Sugarman
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

7.  Identifiability and privacy in pluripotent stem cell research.

Authors:  Rosario Isasi; Peter W Andrews; Jay M Baltz; Annelien L Bredenoord; Paul Burton; Ing-Ming Chiu; Sara Chandros Hull; Ji-Won Jung; Andreas Kurtz; Geoffrey Lomax; Tenneille Ludwig; Michael McDonald; Clive Morris; Huck Hui Ng; Heather Rooke; Alka Sharma; Glyn N Stacey; Clare Williams; Fanyi Zeng; Bartha Maria Knoppers
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

8.  A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research.

Authors:  Jantina de Vries; Akin Abayomi; James Brandful; Katherine Littler; Ebony Madden; Patricia Marshall; Odile Ouwe Missi Oukem-Boyer; Janet Seeley
Journal:  BMC Med Ethics       Date:  2014-08-07       Impact factor: 2.652
  8 in total
  6 in total

1.  Need for DISCUSS(ion).

Authors:  Mahendra S Rao
Journal:  Stem Cells Transl Med       Date:  2015-02       Impact factor: 6.940

Review 2.  Human pluripotent stem cell registry: Operations, role and current directions.

Authors:  Andreas Kurtz; Nancy Mah; Ying Chen; Antonie Fuhr; Sabine Kobold; Stefanie Seltmann; Sabine C Müller
Journal:  Cell Prolif       Date:  2022-05-06       Impact factor: 8.755

Review 3.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

Review 4.  A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.

Authors:  Judy Illes; Douglas Sipp; Erika Kleiderman; Shelly Benjaminy; Rosario Isasi; Geoff Lomax; Zubin Master; Jennifer McCormick; Ubaka Ogbogu; Vardit Ravitsky; Julie M Robillard; Fabio Rossi; Brenda Wilson; Amy Zarzeczny
Journal:  NPJ Regen Med       Date:  2017-07-05

5.  Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development.

Authors:  Glyn N Stacey; Jingyi Cao; Baoyang Hu; Qi Zhou
Journal:  Cell Prolif       Date:  2022-08       Impact factor: 8.755

6.  The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.

Authors:  Michael Morrison; Jessica Bell; Carol George; Shawn Harmon; Megan Munsie; Jane Kaye
Journal:  Regen Med       Date:  2017-10-04       Impact factor: 3.806
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.